4//SEC Filing
RXi Pharmaceuticals Corp 4
Accession 0001209191-17-007742
$PHIOCIK 0001533040operating
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 5:22 PM ET
Size
5.3 KB
Accession
0001209191-17-007742
Insider Transaction Report
Form 4
Dorman H. Paul
Director
Transactions
- Award
Stock option (right to buy)
2017-02-01+2,000→ 2,000 totalExercise: $0.63Exp: 2027-02-01→ Common Stock (2,000 underlying)
Footnotes (1)
- [F1]The stock option vests in equal quarterly installments over one year beginning on the first quarterly anniversary of the grant date.
Documents
Issuer
RXi Pharmaceuticals Corp
CIK 0001533040
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001533040
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 5:22 PM ET
- Size
- 5.3 KB